These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 24974232)

  • 1. Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial.
    Palazzuoli A; Pellegrini M; Ruocco G; Martini G; Franci B; Campagna MS; Gilleman M; Nuti R; McCullough PA; Ronco C
    Crit Care; 2014 Jun; 18(3):R134. PubMed ID: 24974232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous infusion of furosemide combined with low-dose dopamine compared to intermittent boluses in acutely decompensated heart failure is less nephrotoxic and carries a lower readmission at thirty days.
    Aziz EF; Alviar CL; Herzog E; Cordova JP; Bastawrose JH; Pamidimukala CK; Tojino A; Park TS; Musat D; Kukin M
    Hellenic J Cardiol; 2011; 52(3):227-35. PubMed ID: 21642071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous infusion versus bolus injection of loop diuretics for acute heart failure.
    Rasoul D; Zhang J; Farnell E; Tsangarides AA; Chong SC; Fernando R; Zhou C; Ihsan M; Ahmed S; Lwin TS; Bateman J; Hill RA; Lip GY; Sankaranarayanan R
    Cochrane Database Syst Rev; 2024 May; 5(5):CD014811. PubMed ID: 38775253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure.
    Shah RV; McNulty S; O'Connor CM; Felker GM; Braunwald E; Givertz MM
    Am Heart J; 2012 Dec; 164(6):862-8. PubMed ID: 23194486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure.
    Allen LA; Turer AT; Dewald T; Stough WG; Cotter G; O'Connor CM
    Am J Cardiol; 2010 Jun; 105(12):1794-7. PubMed ID: 20538132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous infusion vs. intermittent bolus injection of furosemide in acute decompensated heart failure: systematic review and meta-analysis of randomised controlled trials.
    Ng KT; Yap JLL
    Anaesthesia; 2018 Feb; 73(2):238-247. PubMed ID: 28940440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety.
    Ng TM; Hshieh S; Chan CY; Elkayam U
    J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):373-81. PubMed ID: 22610091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early diuretic strategies and the association with In-hospital and Post-discharge outcomes in acute heart failure.
    Fudim M; Spates T; Sun JL; Kittipibul V; Testani JM; Starling RC; Tang WHW; Hernandez AF; Felker GM; O'Connor CM; Mentz RJ
    Am Heart J; 2021 Sep; 239():110-119. PubMed ID: 34052212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical effects and safety of different strategies for administering intravenous diuretics in acutely decompensated heart failure: a randomised clinical trial.
    Llorens P; Miró Ò; Herrero P; Martín-Sánchez FJ; Jacob J; Valero A; Alonso H; Pérez-Durá MJ; Noval A; Gil-Román JJ; Zapater P; Llanos L; Gil V; Perelló R
    Emerg Med J; 2014 Sep; 31(9):706-13. PubMed ID: 23793945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diuretic strategies in patients with acute decompensated heart failure.
    Felker GM; Lee KL; Bull DA; Redfield MM; Stevenson LW; Goldsmith SR; LeWinter MM; Deswal A; Rouleau JL; Ofili EO; Anstrom KJ; Hernandez AF; McNulty SE; Velazquez EJ; Kfoury AG; Chen HH; Givertz MM; Semigran MJ; Bart BA; Mascette AM; Braunwald E; O'Connor CM;
    N Engl J Med; 2011 Mar; 364(9):797-805. PubMed ID: 21366472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine: The ROPA-DOP Trial.
    Sharma K; Vaishnav J; Kalathiya R; Hu JR; Miller J; Shah N; Hill T; Sharp M; Tsao A; Alexander KM; Gupta R; Montemayor K; Kovell L; Chasler JE; Lee YJ; Fine DM; Kass DA; Weiss RG; Thiemann DR; Ndumele CE; Schulman SP; Russell SD;
    JACC Heart Fail; 2018 Oct; 6(10):859-870. PubMed ID: 30098962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor concordance between different definitions of worsening renal function in patients with acute exacerbation of chronic heart failure: a retrospective study.
    De Vecchis R; Baldi C; Di Biase G
    Minerva Cardioangiol; 2016 Apr; 64(2):127-37. PubMed ID: 25423291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short and long-term effects of continuous versus intermittent loop diuretics treatment in acute heart failure with renal dysfunction.
    Palazzuoli A; Pellegrini M; Franci B; Beltrami M; Ruocco G; Gonnelli S; Angelini GD; Nuti R
    Intern Emerg Med; 2015 Feb; 10(1):41-9. PubMed ID: 25087085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure.
    Singh D; Shrestha K; Testani JM; Verbrugge FH; Dupont M; Mullens W; Tang WH
    J Card Fail; 2014 Jun; 20(6):392-9. PubMed ID: 24704538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
    Paterna S; Di Pasquale P; Parrinello G; Amato P; Cardinale A; Follone G; Giubilato A; Licata G
    Eur J Heart Fail; 2000 Sep; 2(3):305-13. PubMed ID: 10938493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous versus intermittent use of furosemide in patients with heart failure and moderate chronic renal dysfunction.
    Zheng Z; Jiang X; Chen J; He D; Xie X; Lu Y
    ESC Heart Fail; 2021 Jun; 8(3):2070-2078. PubMed ID: 33689236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
    Paterna S; Di Pasquale P; Parrinello G; Fornaciari E; Di Gaudio F; Fasullo S; Giammanco M; Sarullo FM; Licata G
    J Am Coll Cardiol; 2005 Jun; 45(12):1997-2003. PubMed ID: 15963399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.